DGX250117C175000
- 0.65
- 0.000.00%
Quest Diagnostics Newsroom
Citi's Themes: Top Stocks in AI, Leisure, Fin-tech, Video Gaming, Etc. Vs. Their SA Quant Ratings
Quest Diagnostics Incorporated (NYSE:DGX) Might Not Be As Mispriced As It Looks
Leerink Partners Upgrades Quest Diagnostics(DGX.US) to Buy Rating, Raises Target Price to $174
Quest Diagnostics Raised to Outperform From Market Perform by Leerink Partners
Quest Diagnostics Analyst Ratings
Express News | Quest Diagnostics Inc : Leerink Partners Raises to Outperform From Market Perform; Raises Target Price to $174 From $169
Santa Clause Came and Went Without Bringing Gifts | Weekly Buzz
Friday? More Like Grinch Day | Wall Street Today
Why Quest Diagnostics (DGX) Is Poised to Beat Earnings Estimates Again
Santa Claus Came Without Rallying the Troops | Live Stock
Quest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025
How Is The Market Feeling About Quest Diagnostics?
Should You Hold Quest Diagnostics Stock in Your Portfolio Now?
Market Falling Monday, With Few Santa Clause 'Rally' Days Left | Live Stock
Weekly Buzz: So far, Santa is Letting us Down
Friday Market Pulls Back, Led by Mag Seven Decline | Live Stock
Mizuho Securities Maintains Quest Diagnostics(DGX.US) With Buy Rating, Announces Target Price $177
Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management
Mizuho Adjusts Price Target on Quest Diagnostics to $177 From $174, Keeps Outperform Rating
Friday Opens With Falling Prices, but Market Turns Around | Live Stock